Faeth Therapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Austin, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
29
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Faeth Therapeutics Inc. market cap is $275.24M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Faeth Therapeutics Inc. 52 week high is $42.14 as of November 14, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Faeth Therapeutics Inc. 52 week low is $7.45 as of November 14, 2026.
Faeth Therapeutics Inc. stock price today is $10.03.
Faeth Therapeutics Inc. stock price yesterday was $10.65.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Faeth Therapeutics Inc.'s P/E ratio is -0.08.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Faeth Therapeutics Inc. P/B ratio is 1.7084.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Faeth Therapeutics Inc. 50-day moving average is $25.65.
